A new approach to gene therapy

Blood Coagulation and Fibrinolysis

Volumn 8, Issue SUPPL. 2, 1997, Pages

  Zhang, Zhiping ^a   Eriksson, Maria ^a,b   Blombäck, Margareta ^b   Anvret, Maria ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Department of Clinical Neuroscience ^*

Author keywords

Gene therapy; Mutation repair

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; OLIGODEOXYRIBONUCLEOTIDE; OLIGORIBONUCLEOTIDE;

CHIMERA; CONFERENCE PAPER; DNA REPAIR; GENE MUTATION; GENE TARGETING; GENE THERAPY; HEMOPHILIA A; HEMOPHILIA B; HUMAN; PRIORITY JOURNAL; VON WILLEBRAND DISEASE;

ANIMALS; GENE TARGETING; GENE THERAPY; HEMOPHILIA A; HEMOPHILIA B; HUMANS; VON WILLEBRAND DISEASE;

EID: 0031431446     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (11)

1. Mulligan RC: The basic science of gene therapy. Science 1993, 260:926-932.
2. Kotin RM, Siniscalco M, Samulski RJ, et al.: Site-specific integration by adeno-associated virus. Proc Natl Acad Sci USA 1990, 87:2211-2215.
3. Yoon K, Cole-Strauss A, Kmiec EB: Targeted gene correction of episomal DNA in mammalian cells mediated by a chimeric RNA/DNA oligonucleotide. Proc Natl Acad Sci USA 1995, 93:207-2076.
4. Cole-Strauss A, Yoon K, Xiang YF, et al.: Correction of the mutation responsible for sickle cell anemia by an RNA/DNA oligonucleotide. Science 1996, 273:1386-1389.
5. Liu Y, Mounkes LC, Liggitt HD, et al.: Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nature Biotechnol 1997, 15:167-173.
6. Fender P, Ruigrok RWH, Gout E, Buffet S, Chroboczek J: Adenovirus dodecahedron, a new vector for human gene transfer. Nature Biotechnol 1997, 15:52-56.
7. Giannelli F, Green PM, Sommer SS, et al.: Haemophilia B: database of point mutations and short additions and deletion, 7th edition. Nucleic Acids Res 1997, 25:133-135.
8. Tuddenham EG, Schwaab R, Seehafer J, et al.: Haemophilia A: database of nucleotide substitutions, deletions, insertions and rearrangements of the factor VIII gene, second edition. Nucleic Acids Res 1994, 22:3511-3533.
9. Evans JP, Brinkhous KM, Brayer GD, Reisner HM, High KA: Canine hemophilia B resulting from a point mutation with unusual consequence. Proc Natl Acad Sci USA 1989, 86:10095-10099.
10. Zhang ZP, Falk G, Blombäck M, Egberg N, Anvret M: A single cytosine deletion in exon 18 of the von Willebrand factor gene is the most common mutation in Swedish vWD type III patients. Hum Mol Genet 1992, 1:767-768.
11. Zhang ZP, Blombäck M, Egberg N, Falk G, Anvret M: Characterization of the von Willebrand factor gene in vWD type III patients from 24 families with Swedish and Finnish origin. Genomics 1994, 21:188-193.